-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials
Ramit Ravona-Springer, Amos D Korczyn
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation
-
Novel clinical trials in neuro-oncology
Aaron G Mammoser, David E Blas-Boria1 & Mark R Gilbert
Review Article: Clinical Investigation